1596results about How to "Convenient for clinical operation" patented technology

The present invention discloses novel dendritic cell maturation-inducing cytokine cocktails, and methods for inducting type-1 polarized dendritic cells in serum-free conditions which enhance the desirable properties of DC1s generated in serum-supplemented cultures. The invention further discloses methods and systems using IFNγ and other ligands of the IFNγ receptor, in combination with IFNα (or other type I interferons), poly I:C, and other IFNα (and IFNβ) inducers to enhance the IL-12-producing properties of dendritic cells. More specifically, the present invention discloses type-1 polarized dendritic cells that have a unique combination of a fully-mature status and an elevated, instead of “exhausted”, ability to produce IL-12p70. allows for the generation of fully-mature DC1s in serum-free AIM-V medium. The invention discloses systems that use the foregoing products and methods to facilitate the clinical application of DC1-based vaccines and the identification of novel factors involved in the induction of Th1 and CTL responses by DC1.

The present invention is objective, quantitative and precise method of predicting serious complication risk degree after gastric cancer operation. The method includes the following steps: 1. screening out factors affecting the serious complication after gastric cancer operation through overall single factor analysis; 2. determining the prognostic determining factor through two-value multiple non-conditional logic regression analysis; 3. determining the optimal prediction value dividing value through the work characteristic analysis on the testee; and 4. establishing the predicting model with main risk factor as the independent variable and judging the serious complication risk degree after gastric cancer operation by means of the prediction probability. The present invention is one objective and quantitative intelligent risk evaluation system.

The invention provides a medical anti-sticking membrane and a preparation method thereof. The anti-sticking membrane comprises a nanometer frame and hydrosol attached thereon. The hydrosol is internally packed with one or several kinds of styptic medicament or/and anti-sticking medicament. The invention also provides a preparation method of the anti-sticking membrane, comprising the following steps of: preparing electro-spinning solution, styptic medicament and/or anti-sticking medicament-containing hydrosol solution and crosslinker solution; receiving static spinning with the crosslinker solution to obtain the nanometer frame; printing the styptic medicament and/or anti-sticking medicament-containing hydrosol solution onto the nanometer frame by an ink-jet printer, and solidifying the hydrosol solution to obtain the anti-sticking membrane. The anti-sticking membrane has good capability and biological compatibility, and nontoxicity as well as nonirritant, can be completely degraded and absorbed, is compounded with controllably released styptic medicament or/and anti-sticking medicament, has controllable degrading time and speed, and conquers defects of the prior art.

A non-contact type dental shade matching device is provided, comprising a camera body for capturing image of one or more target teeth; an opaque intra-oral compartment snugly adapted for a human mouth; an opaque cover shield body connected between the camera body and the intra-oral compartment; one or more holders for holding one or more shade tabs; and a color matching module being operably connected to the camera body to receive the captured images containing color and translucency information of the target tooth and/or shade tab information, and then to process the images based on a content-based algorithm for automatic shade matching between the target tooth and the shade tabs for each of the captured images, so as to achieve an optimal dental prosthesis.

The invention refers to a preparation method of ginseng polysaccharide. The method includes the following step: extract it from the ginseng or the marc of the ginseng decocted, filtrate, concentrate and deposit the extracting solution, get the precipitate after centrifugence and dry it with low temperature to get the crude product of ginseng polysaccharide. We get the polysaccharide product after the ginseng polysaccharide goes through the boiling, depositing, filtration, trash extraction, frost thawing, getting rid of the protein and getting the supernatant and the supernatant passes through the concentration with low pressure and drying with low temperature. We can make it into all kinds of forms of prepared drugs after the ginseng polysaccharide passes through the experiments in pharmaceutics. The invention effectively increases the quality of the ginseng polysaccharide injection, fully exerts the immunoloregulation function of the ginseng polysaccharide, increases the anti tumor effect of chemotherapy medicament and is used to reduce the side effect caused by the knubbly radiotherapy and chemotherapy as well as adjuvant for curing the tumor.

The invention discloses an acellular matrix with natural level of glycosaminoglycan and preparation and application thereof. The preparation method comprises the following steps: carrying out acellular disposal on natural biological tissue to obtain an acellular matrix; detecting missing amount of glycosaminoglycan in the acellular matrix; and supplementing glycosaminoglycan by means of natural ingredients in the acellular matrix to obtain the acellular matrix with natural level of glycosaminoglycan. Through the method, a lot of the glycosaminoglycan component in the acellular matrix is recovered. The acellular matrix has good biocompatibility. The natural biological structure is recovered, and the acellular matrix is beneficial to cell growth. glycosaminoglycan is supplemented for the acellular matrix, and a tissue engineering carrier is constructed. According to the invention, a biological carrier which meets cell growth requirement and mechanical strength requirement and has similar structural components as a natural extracellular matrix can be prepared rapidly. The invention is a great breakthrough of the tissue engineering construction technology. Meanwhile, principle of the invention is reliable, the technology is simple and flexible, product reproducibility is good, and industrialization is easy to realize.

The invention provides a medical dressing for protecting skin wounds and promoting repairing, an application of the medical dressing and a preparation method of the medical dressing. The medical dressing comprises a biological plural gel film dressing and a medical polyurethane adhesive film; the biological plural gel film dressing is composed of raw materials of a framework material synthesized by polyanion substances and polycation substances, hyaluronic acid, polypeptide and bonding polypeptide; and the potential of hydrogen (pH) value of the biological plural gel film dressing is 5.8-6.4. The medical dressing for protecting the skin wounds and promoting repairing of the skin wounds has the advantages of wound covering medical dressings, more importantly, by means of synergistic actions of the bonding polypeptide and the hyaluronic acid, the structural designs of medical dressing materials are optimized, and additional growth factors or living cells are not required for enabling the medical dressing materials to have functions of in-situ inducing tissue regeneration and repair.

The invention provides a nano artificial dura mater capable of being used as a medicine sustained-release system, having the structure which comprises at least two layers, i.e. a hydrophobic anti-blocking electro-spun layer which faces the cerebrum, and a hydrophilic nano cytoskeleton layer which backs on to the cerebrum; and cell factors and/or medicines are arranged in any layer of the artificial dura mater by way of blended spinning. The invention also provides a method for preparing the nano biomimic artificial dura mater. Compared with an artificial mater prepared by the single utilization of the electro-spinning technology, the artificial mater to which the medicines and the cell factors are added by blending technology can effectively prevent infection and faster promote the regeneration process of the artificial mater. The invention also provides a novel medicine loading and releasing mode for treating cerebral diseases, the loaded medicines can be directly and efficiently transferred into the cranial cavity along with the implantation of the dura mate and can be released according to requirements, and therefore the invention realizes favorable treatment effect and has broad application prospect.

The invention discloses a direct venous re-transfusion immune cell cryopreservation medium and application thereof. The direct venous re-transfusion immune cell cryopreservation medium is prepared from dimethyl sulfoxide, human serum albumin, dextran, hydroxyethyl starch, heparin sodium and other clinical medicinal level raw materials by optimizing the proportion of the dose of each raw material. In addition, the operation steps are simplified and the cryopreservation effect is improved by optimizing the cryopreservation method. On one hand, the potential risk of introducing an animal source antigenic substance in the cell treatment process is avoided, and on the other hand, the cryopreservation effect of immune cells is better than that of a conventional cryopreservation medium, thereby guaranteeing the safety and validity in clinical use. Two kinds of components are used for preservation, so that the cryopreservation medium can be preserved stably for a long time. The method disclosed by the invention is simple in operation, provides stronger operability for implementation of large-scale cryopreservation, and simultaneously provides a fundamental technical guarantee for implementation of immune cell treatment.

The invention relates to a nano micelle of a biodegradable macromolecular-bonding Pt(IV) anti-cancer medicament and a preparation method thereof. The structural formula of the anti-cancer medicament is defined in the specification, wherein the biodegradable macromolecule is tri-block copolymer, namely polyethylene glycol-b-polyester-b-polylysine; and tetravalency platinum coordination compound Pt(IV) is connected with a side amino on the block of polylysine on a macromolecular carrier through alpha, omega-polyethylene glycol. The carrier is non-toxic and is water-soluble, thus being convenient for reacting with the platinum(IV) coordination compound in water phase; a nano micelle form can be formed through self assembly; a platinum(IV) coordination compound is reduced to platinum(II), namely, cis-platinum, Carboplatin or Oxaliplatin, and the anti-cancer effect is known; the synthesis of the nano micelle is easy; the reduction potential of platinum(IV) is low, so that the platinum(IV) can be rapidly reduced to platinum(II) in cancer cells to take treatment effect; and the platinum(IV) is connected to the side chain of the macromolecule rather than the end of a chain, a macromolecular chain can be connected with multiple platinum(IV)s, and the content of platinum can be as high as 10-20%.

A staltic soluble cellulose sponge is proportionally prepared from carboxymethyl cellulose sodium and chitosan through dissolving carboxymethyl cellulose sodium in distilled water, dissolving chitosan in diluted acetic acid, mixing, adding polyethanediol 400, cane sugar and glycerin, stirring, laying aside while defoaming, filming, and vacuum freeze-drying.

The three dimensional measuring device used in the dental field and aimed at measuring in the absence of projection of active or structured light, includes an image-capturing device and data-processor for images. The image-capturing device is capable of simultaneously, or almost simultaneously, capturing at least two images, one of which is totally or partially included in the other one. The included image describes a narrower field than that of the other one, and has a higher accuracy than that of the other one.

A freeze-dried liposoluble vitamin with high water solubility and stability and its preparing process is also disclosed.

The invention relates to a dispersion system with docetaxel as main component for injection, comprising a surfactant, an assistant surfactant and a specified amount of oil for injection. The volume ratio of oil phase to the surfactant is greater than 3 percent as well as less than and equal to 33 percent. The volume ratio of the assistant surfactant to surfactant is greater than or equal to 12.5 percent and less than 167 percent.

The invention relates to the technical field of gene detection, in particular to a CRISPR (Clustered regularly interspaced short palindromic repeats)/Cas12 one-step nucleic acid detection method and a2019-nCoV detection kit. The 2019-nCoV detection kit comprises crRNA, Cas protein, a primer, a buffer system and single stranded DNA reporter molecules; the primer is obtained as follows: 5'-TTTN-3'sequence is sought in a to-be-detected target molecule area, a forward primer is designed in the position near 5' area 0-200bp, a reverse primer is designed in the position near 3' area 25-200bp, theobtained primer is subjected to chemical modification to prevent decomposition of DNA enzyme or Cas12 protein after activation. The method has the benefits that compared with existing PCR-based nucleic acid detection technologies, the nucleic acid detection method and the 2019-nCoV detection kit can allow synchronous amplification and detection, thus, operation is more convenient.

The invention relates to a multifunctional particle used for stopping human body wounds bleeding, filling, absorbing fluid, preventing adhesion and inducing tissue regeneration and repair. The absorbable particle with multiple functions of stopping bleeding, filling, absorbing the fluid, preventing the adhesion and inducing the tissue regeneration and repair comprises the following raw materials in weight percentage: 30-98.95 percent of polyanionic substance, 1-70 percent of cationic substance and/or polycationic substance, 0.05-2 percent of hyaluronic acid and/or functional factor polypeptide and 0-68.95 percent of pharmaceutical excipient. The particle is 0.01-1.0mm in particle size, and the particle is irregular in shape. The absorbable particle material with the multiple functions of stopping bleeding, filling, absorbing the fluid, preventing the adhesion and inducing the tissue regeneration and repair can be used for stopping the human body wounds bleeding, filling, absorbing fluid, preventing the adhesion and inducing the tissue regeneration and repair and is especially suitable for the wounds and defective tissues during minimally invasive surgery.